A robust post-approval regulatory system ensures ongoing compliance via safety surveillance, regulatory maintenance, licensing renewals, labeling updates, and integrated quality and risk management for sustained product success.
This guide details key cosmetics regulations in the US (MoCRA), EU/UK, and Canada, emphasizing compliance steps, documentation, and expert support from Arora 297 Consultancy for global market success.
Integrate regulatory intelligence into your compliance program by building structured data collection, analysis, and actionable insights within your QMS to reduce risks, speed approvals, and ensure post-market safety.
Best practices for US and Canadian pharma submissions include thorough preclinical data, regulatory alignment, pre-submission meetings, robust data management, eCTD training, compliance with CMC/stability standards, and proactive agency engagement.
Early strategic regulatory guidance streamlines FDA and Health Canada approvals, reduces delays, ensures compliance, and accelerates market entry, enhancing competitive advantage and business growth.
FDA and Health Canada updated medical device approval rules, affecting classifications, evidence, submissions (eSTAR, UDI), licensing, QMSR, and post-market requirements. Strategic compliance ensures timely market entry.
Strong Quality Management Systems (QMS) like ISO 13485 and FDA QMSR ensure regulatory compliance, faster approvals, fewer inspection issues, and sustained global market access. Arora 297 Consultancy offers expert QMS…
In 2026, pharma and medical device compliance demands early FDA QMSR updates, Health Canada regulatory shifts, eSTAR submissions, digital health and cybersecurity adherence, UDI implementation, robust post-market surveillance, continuous manufacturing…
Build a regulatory intelligence program by identifying risks, tracking FDA and Health Canada updates, using horizon scanning and assessment tools, and sustaining compliance via quality management and post-market surveillance.
Guide details US FDA and Health Canada medical device market entry, covering classification, FDA 510(k), De Novo, PMA, QMS standards (21 CFR 820, ISO 13485), registrations, UDI, and licensing requirements.
Call Now Button